CASES: DIABETES AND PREGNANCY

Size: px
Start display at page:

Download "CASES: DIABETES AND PREGNANCY"

Transcription

1 CASE 1: Visit 1: Ms. Sunny Disposition is a 32 yo G2P1001 who is approximately 15 weeks here for her first prenatal visit. She has already had an US but records not yet received. Pmhx: Unremarkable, no chronic medical problems, no meds. Obstetrical hx: G1 born in 2000 notable for 8 pound 10 ounce male born at term via NSVD. He has a developmental delay and is 10 years old but has IQ of 6 year old per mom. On physical exam 98 KG, height 158 cm, BMI 40 BP 110/56 P 92 Otherwise normal full exam. What do you want to order? Pap, Prenatal labs, HbA1C and fasting blood sugar if feasible. Consider TSH. 4 days later labs are back. All prenatal labs are within normal limits except HbA1C 7.9. US at 8 weeks 1 day puts her at 14 weeks today. What is her diagnosis? Type II DM. What is the treatment plan? Call patient and order test strips, glucometer, lancets, send to diabetes education. Offer to send patient to genetic counseling (Type 2 DM is at higher risk of congenital abnormalities). Follow weekly. 1

2 Visit 2: Sunny is now at 17 weeks. Went to DM education, got glucometer, told lancets not covered by insurance. What do you do? Call pharmacy, check and see which glucometer and lancets are covered and order correct ones. Don't do what Jessi did and give her $20 to get lancets covered...never saw that money again! Visit 3: Sunny is at 18 weeks. Got lancets through insurance. Fastings now , 2-hour postprandials are in the 120's. What do you want to do? Start meds. OB/GYN covering for holiday started on Glyburide 2.5 po qhs, but discuss that this is not what we recommend starting her on. At least 5 mg po q day. Discuss metformin and insulin as alternatives. What side effects do you need to warn patient about? Hypoglycemia with insulin and glyburide. Diarrhea with metformin. Visit 4: Sunny is at 19 weeks and has 5 elevated fastings in range and 2 elevated post prandials in the 130's. Now what would you like to do? There are alternatives but she was increased to 5 mg po qhs of glyburide. 19 wk US: HC 48% AC 57% EFW 51% placenta posterior and normal AFI. Recommendation on scan is to repeat in 4 weeks as cardiac outflow tracts not well seen. Visit 5: Sunny is at 20 weeks and has 4 elevated fastings in range, post-prandials 2 elevated at 2 different meals. 2

3 What adjustments would you make? Glyburide adjusted to 2.5 mg po q am and 7.5 mg qhs. Visit 6: Sunny is at 22 weeks and missed one visit. She had some low sugars in the 60's with symptoms and decreased self to 7.5 mg qhs. Visits 7,8,9: Well controlled. Noted at 25 weeks to be size> dates fundal height at 30 cm. 26 wk US: HC 75% AC 47% EFW 57% afi 15.6 cm posterior placenta no previa. No gross fetal abnormalities. Normal echo. Visits 10-11: has 2 elevated fastings at visit 11 and glyburide increased to 10 mg po qhs. Visit 12: 30 weeks well controlled. Not seen again in clinic until 34 weeks. Missed 32 week US. Visit 13: Forgot log. Per patient controlled. US ordered stat and set up for antenatal testing. What does antenatal testing include? Weekly AFI and bi-weekly NST When do we usually set this up for? 32 weeks if well controlled, weeks if poor control. 34 week US: HC 96% AC> 97% EFW 3248 grams > 90% AFI % placenta posterior, breech. Visits14-15: weeks: 1 abnormal lunch postprandial, o/w all nl per pt, but didn't bring log. GBS negative. 3

4 Visit 16: vertex in antenatal testing IOL scheduled for 39 weeks. At 37 6/7 seen in OB Triage with elevated SBP 140, pr/cr ratio 0.8, nl PIH labs. Asymtomatic. What do you think, would you send her home? No. Presumed preeclampsia based on elevated pr/cr ratio and elevated BP. Considering past 37 weeks, she should be delivered. IOL started: cervix closed/ thick/ high. Miso placed, once at 1 cm cook catheter placed. From there went quickly 4 hours to complete. Pushed 2 minutes. Shoulder dystocia relieved after 1 minute with McRobert's, Suprapubic pressure and internal wood screw maneuver. No laceration. Baby girl 4575 grams. Required 1-week management in hospital for sugars. Ms. Sunny at 12 weeks postpartum HBA1C 7.0. Type 2DM now diagnosed. This is a real case. In retrospect, was there anything that could have been done differently? Considering 34 week Ultrasound, could have considering repeat US weeks and consider delivering at 37 weeks. She had dating based on 8 week US, but if dating was poor would consider doing amniocentesis for fetal lung maturity if considering delivering at 37 weeks. HBA1C in every trimester might have determine if patient being non-compliant with recommendations. 4

5 CASE 2: Ms. Positively Beaming is a 26 yo G1P0 is 11 weeks 6/7 days by an ultrasound at Carenet here to establish prenatal care. PMHx: Previous diagnosis of PCOS on Metformin 1000 mg XL. No other past medical problems. Pex: 128 KG, BP 120/70 P 60 Morbidly Obese. What do you want to order? Pap, Prenatal labs, HbA1C and fasting blood sugar if feasible. Consider TSH. Discuss MSAFP testing. Dating ultrasound as Carenet (pro-life church affiliated organization) ultrasound is not a true medical US (That's what I've been told in the past, but on their website it does say US are reviewed by radiologists). 2 days later labs are back: HBA1C 6.3, FBS 86. What is the diagnosis? Uncertain. If she was not on metformin then it would be glucose intolerant, but metformin makes diagnosis less clear. She could be a Type II DM whose BS level is improved because of metformin. What do you want to do? Schedule for sequential screen if interested, set up for genetic counseling, diabetes education. Order repeat screen. 2 hour OGTT ordered at 18 weeks. Order glucometer, test strips, lancets. 5

6 Visit 2: Dating confirmed and now 15 weeks. Placed on metformin 1000 mg bid as XL not well studied in pregnancy. Scheduled for 2 hour glucose tolerance test at 18 weeks. Visit 3: Now 19 weeks. 1 abnormal on 2 hour glucose tolerance test. Started checking sugars but has not met with DM education. Fastings: 62, 96, 196, 108. PP ok except breakfast 156 and 2 dinner PP 140, 142. What do you recommend? Again, go through options. As was already on Metformin, felt she would likely need insulin so she was given Rx for insulin, lancets, and syringes. She was set up for insulin teaching with pharmacist. Fetal Echo and US for anatomy scheduled at 20 weeks. Visit 4, 5,6: Adjusting insulin. NPH at 20 units per night, increased from 10 units over phone. Breakfast PP 1 elevated 134, lunch 1 elevated 122, Dinner 1 at 142. Started on Lispro 5 unit per meal. Visit 7: Elevated x 3: fasting 97 breakfast 140, dinner 128. NPH placed at 25 units and lispro 7 units per meal. Assuming she is Type II DM, what else should be ordered if it hasn't been already? Type II DM are at risk for chronic organ injury so should order: EKG, baseline PIH labs, 24-hour urine protein for baseline, urine microalbumin, baseline eye exam. HBA1C in every trimester remembering not accurate, but can give indicator if poor control. Visit 8: 28 weeks. 4 elevated fastings at 97,98, 101, 117. PP elevated breakfast 144, dinner 143 otherwise wnl. Echo nl, HC 62% AC 37% EFW 57%. PIH labs, microalbumin, EKG nl. 24-hour urine protein 136 on liters (1500 ml is considered adequate sample). NPH 28 units, lispro 8 units with meals. 6

7 Visit 9: 30 weeks. adjusted to 15 units with meals and 30 units of nph qhs. WT 132 KG. What would you order now? Antenatal testing should start at 32 weeks. Visits 10-14: Well controlled. US 35 weeks: HC 33% AC 13% EFW 26% 2331 grams, afi 13 cm. vertex placenta posterior no previa. Visit 15-16: 36-37weeks, few BS elevated Adjusted to 18/15/18 and 35 units NPH. US 38 weeks : HC 66% AC 75% 3264 grams 79% AFI 19.8 cm Visit 17: 38 weeks. Getting hypoglycemic on 18 units TID lispro and not requiring NPH at all last 3 days. What could be going on? Uterine-placental insufficiency leading to less insulin resistance. What should be done? As she is at term, good idea to schedule IOL now. Outcome: At 38 1/7 brought in for IOL. After 3 day IOL, and developing preeclampsia, and s/p magnesium. Failed to dilate past 5 cm despite 4 hours adequate contractions so primary LTCS was done for failure to progress gram female Apgars 7 and 8 OA. After 6 hour transition in ICN 3 was with mom and went home with mom PPD #2. 7

8 POSTPARTUM F/U: 8wks PP HbA1C 5.7. wt 127 KG, which was slightly less than pre pregnancy weight. Encouraged to continue to breastfeed and continue good habits established in pregnancy. CASE 3: Present if time allows... Ms. Life on the Bright side is a 35 yo G2P1000 at 20 4/7 weeks by 1st trimester US per her report at Presbyterian who is known Type 2 DM on insulin. She is transferring care because she wants to be very aggressive with her care due to history of death with last baby. Pmhx: Glyburide prior to pregnancy Current meds: NPH 58 units Novolog 36/26/26. OBhx: G1 Born at full term by emergency C/S in Nigeria and per patient died at Day 2 of life from complications of unknown cause. Patient believes it was diabetes related. Patient received very little prenatal care. 8 pound 13 ounce male, no records available. On Pex: BMI 24 BP 128/78 P 76 Fasting Breakfast Lunch Dinner What labs/test should be ordered? Get old records. HBA1C at 10 weeks Order PIH labs, Baseline 24 hour urine protein, urine microalbumin, EKG, set up optho referral, fetal echo, genetics counseling if not already done. Repeat HbA1C. 8

9 What should we do with her sugars? Send to DM education, consider metformin as may increase insulin sensitivity. This was offered but patient refused. Labs show HbA1c 8.6, repeat 4 weeks later 7.3. PIH labs nl EKG nl and pr/cr 0.2 done instead of 24 hour urine protein as patient sample inadequate. 23 weeks: HC 61% AC 62% EFW 58% posterior placenta no previa, echo not done. 27 weeks : echo wnl. 28 weeks: up to 78 units NPH 56/46/30 Novolog, coming to appointments diligently. US 29 weeks: HC 80% AC 77% EFW 75% nl interval growth and nl AFI weeks slight adjustments but essential same insulin requirements What does she need at 32 weeks? Antenatal testing US 34 weeks: Vtx HC 68% AC 83% EFW 82% AFI 14 nl interval growth. 36 weeks GBS neg NPH 90 units 68/65/ well controlled 39 weeks Transverse on US. Admitted for ERCS, then vtx. POC glucose 84. Outcome : 3690 grams, oblique lie Apgars 6, 9,10. Repeat LTCS. Initially baby transitioned well but in NBN blood glucose 40 after feeds persistently, taken to NICU, required IV glucose and 2-day stay in NICU. 9

CASES: DIABETES AND PREGNANCY

CASES: DIABETES AND PREGNANCY CASE 1: Visit 1: Ms. Sunny Disposition is a 32 yo G2P1001 who is approximately 15 weeks here for her first prenatal visit. She has already had an US but records not yet received. Pmhx: Unremarkable, no

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Resident School November 5 2014 Goals Be able to screen for gestational and preexisting diabetes Be able to counsel women on the diagnosis of gestational diabetes Understand glucose

More information

Management of Pregestational and Gestational Diabetes Mellitus

Management of Pregestational and Gestational Diabetes Mellitus Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is

More information

GESTATIONAL DIABETES TESTING AND TREAMENT

GESTATIONAL DIABETES TESTING AND TREAMENT Boston Medical Center Maternity Care Guideline: GESTATIONAL DIABETES TESTING AND TREAMENT Accepted: August 2015 Updated: December 2018 Contributors: Aviva Lee-Parritz, MD, Sara Alexanian, MD, Kari Radoff,

More information

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest. Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives

More information

Management of Gestational Diabetes

Management of Gestational Diabetes Management of Gestational Diabetes A Diabetes risk assessment should be ascertained at the First prenatal visit. Low Risk: Early blood glucose screening is NOT routinely required if most of the following

More information

CommUnityCare Women s Health Brackenridge Professional Office Building

CommUnityCare Women s Health Brackenridge Professional Office Building Guidelines for Diabetes in Pregnancy Effective Date 7/1/11 *This document does not define a standard of care, nor is it intended to dictate an exclusive course of management. There are other accepted strategies

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the

More information

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network Gestational Diabetes Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network Outline Definition Prevalence Risk factors complications Diagnosis Management Nonpharmacologic

More information

2018 Standard of Medical Care Diabetes and Pregnancy

2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Disclosure Diabetes in Pregnancy I have no conflicts of interest to disclose Jennifer Krupp, MD Maternal Fetal Medicine St. Marys Hospital/SSM Health Madison, WI Objectives Classification of Diabetes Classifications

More information

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese

More information

Diabetes in Pregnancy. L.Sekhavat MD

Diabetes in Pregnancy. L.Sekhavat MD Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes

More information

APEC Guidelines Gestational Diabetes Mellitus

APEC Guidelines Gestational Diabetes Mellitus Gestational diabetes mellitus (GDM) is defined as insulin resistance of variable severity with onset or first recognition during pregnancy. The prevalence of diabetes mellitus (DM) in the US is growing

More information

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.

More information

Gestational Diabetes. Gestational Diabetes:

Gestational Diabetes. Gestational Diabetes: Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,

More information

The Ever-Changing Approaches to Diabetes in Pregnancy

The Ever-Changing Approaches to Diabetes in Pregnancy The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches

More information

Diabetes and Pregnancy

Diabetes and Pregnancy Diabetes and Pregnancy Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine University of North Dakota School of Medicine And Health Sciences Assistant Medical Director

More information

DIABETES WITH PREGNANCY

DIABETES WITH PREGNANCY DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal

More information

Diabetes Related Disclosures

Diabetes Related Disclosures Diabetes Related Disclosures Speakers Bureau Amylin Boehringer Ingelheim Eli Lilly Takeda Classification of Diabetes Diabetes Care January 2011 vol. 34 no. Supplement 1 S11-S61 Type 1 Diabetes Mellitus

More information

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ) Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min

More information

GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016

GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016 GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar Simon Kane March 2016 Objectives History and definitions Definition and Australian data Pathophysiology and prevalence Rationale

More information

Disclosures. Diagnosis and Management of Diabetes in Pregnancy. I have nothing to disclose. Type 1. Overview GDMA1

Disclosures. Diagnosis and Management of Diabetes in Pregnancy. I have nothing to disclose. Type 1. Overview GDMA1 Diagnosis and Management of Diabetes in Pregnancy Kirsten Salmeen, MD Assistant Professor Department of Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine Disclosures I have nothing

More information

APPENDIX American Diabetes Association. Published online at

APPENDIX American Diabetes Association. Published online at APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no

More information

Diabetes is a chronic disease of impaired glucose intolerance caused by absolute or relative insulin deficiency.

Diabetes is a chronic disease of impaired glucose intolerance caused by absolute or relative insulin deficiency. June 2015 Diabetes is a chronic disease of impaired glucose intolerance caused by absolute or relative insulin deficiency. Types of Diabetes Type 1 Type 2 Gestational Diabetes and Pregnancy 0.3% of pregnancies

More information

Rev. date Kaiser Foundation Health Plan of Washington

Rev. date Kaiser Foundation Health Plan of Washington PE3620000-01-17 Rev. date 2014013 2017 Kaiser Foundation Health Plan of Washington Gestational diabetes Information to help you stay healthy during your pregnancy What is gestational diabetes? How gestational

More information

Current Trends in Diagnosis and Management of Gestational Diabetes

Current Trends in Diagnosis and Management of Gestational Diabetes Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives

More information

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION Jaiwant Rangi, MD, FACE Nov 10 th 2018 DISCLOSURES Speaker Novo Nordisk Sanofi-Aventis Boheringer Ingleheim Merck Abbvie Abbott

More information

Application of the Diabetes Algorithm to a Patient

Application of the Diabetes Algorithm to a Patient Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent

More information

Vishwanath Pattan Endocrinology Wyoming Medical Center

Vishwanath Pattan Endocrinology Wyoming Medical Center Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

MANAGEMENT OF DIABETES IN PREGNANCY

MANAGEMENT OF DIABETES IN PREGNANCY MANAGEMENT OF DIABETES IN PREGNANCY Ministry of Health Malaysia Malaysian Endocrine & Metabolic Society Perinatal Society of Malaysia Family Medicine Specialists Association of Malaysia Academy of Medicine

More information

Safe use of insulin regular concentrated (500 units/ml) in severe insulin resistance

Safe use of insulin regular concentrated (500 units/ml) in severe insulin resistance Safe use of insulin regular concentrated (500 units/ml) in severe insulin resistance Jodie S. Gee, Pharm.D., BCACP, CDE Clinical Pharmacy Specialist-Ambulatory Care Harris Health System Objectives To be

More information

Diabetes in Pregnancy: Detection, Intervention, Prevention. Diabetes in Pregnancy: Outline. Diabetes in Pregnancy

Diabetes in Pregnancy: Detection, Intervention, Prevention. Diabetes in Pregnancy: Outline. Diabetes in Pregnancy Diabetes in Pregnancy: Detection, Intervention, Prevention Michael Shannon, MD Chair, Providence Endocrinology/Diabetes CAT Diabetes in Pregnancy: Outline Prevalence, Pathophysiology and Complications

More information

Objectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy

Objectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical

More information

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Clinical Cases in Diabetes Management. Joseph Cook D.O. Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians

More information

Improving Outcomes in Pregnancies Complicated by Diabetes Mellitus

Improving Outcomes in Pregnancies Complicated by Diabetes Mellitus Improving Outcomes in Pregnancies Complicated by Diabetes Mellitus Steven G. Gabbe, M.D. Emeritus Chief Executive Officer Professor, Obstetrics and Gynecology The Ohio State University Wexner Medical Center

More information

Type 2 Diabetes Mellitus Insulin Therapy 2012

Type 2 Diabetes Mellitus Insulin Therapy 2012 Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe

More information

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss

More information

Gestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN

Gestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN Gestational Diabetes: An Update on Testing Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN Gestational Diabetes Increased risks of: Still Birth Hydramnios Should Dystocia Prolonged Labor Preeclampsia

More information

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor

Reason for referral: provide patient education on management of hypoglycemia and glucose monitor Meet Robin Sawyer (otherwise known as PT 1): Let s Create a Care Plan! Reason for referral: provide patient education on management of hypoglycemia and glucose monitor History of present illness: 40 45

More information

Gestational diabetes

Gestational diabetes Southend University Hospital NHS Foundation Trust Patient Information Service Women and children s business unit Gestational diabetes What is gestational diabetes? Gestational diabetes mellitus (GDM) is

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1 Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies

More information

10/9/2017 OBJECTIVES DIABETES REVIEW

10/9/2017 OBJECTIVES DIABETES REVIEW OBJECTIVES MECHANICAL MADNESS: TECHNOLOGY, DIABETES AND PREGNANCY ALYSON BLUM, PHARMD, CDE CLINICAL PHARMACIST IN OBSTETRICS SACRED HEART MEDICAL CENTER, CENTER FOR MATERNAL FETAL MEDICINE WASHINGTON STATE

More information

PREGESTATIONAL DIABETES (TYPE 1 AND 2)

PREGESTATIONAL DIABETES (TYPE 1 AND 2) PREGESTATIONAL DIABETES (TYPE 1 AND 2) Women with diabetes prior to pregnancy need to evaluate and optimize their baseline to assure the healthiest pregnancy possible.[1] The overall prevalence of pregnant

More information

A Challenging Case: Von Willebrand Disease and Pulmonary Hypertension in Pregnancy

A Challenging Case: Von Willebrand Disease and Pulmonary Hypertension in Pregnancy A Challenging Case: Von Willebrand Disease and Pulmonary Hypertension in Pregnancy Diana S. Wolfe, MD, MPH Assistant Professor Department of Obstetrics & Gynecology and Women s Health Associate Fellowship

More information

Who s who on your healthcare team.

Who s who on your healthcare team. Who s who on your healthcare team. Your primary care or family physician (who may be a general practitioner or internist) will likely be at the center of your diabetes healthcare team. Depending on your

More information

Type 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA

Type 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the

More information

Participants in the Program

Participants in the Program Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the

More information

Diabetes Self-Management Education Record

Diabetes Self-Management Education Record Diabetes Self-Management Education Record Patient Label Record level of competence and Initial: O=outcomes met; RT=reinforce teaching; NA=not applicable; P=prior knowledge Clinical Outcomes Information

More information

Preventive Services Explained

Preventive Services Explained Preventive Services Explained Medicare covers many preventive care services without charge. Most of these services have been recommended by the U.S. Preventive Services Task Force. However, which beneficiaries

More information

Diabetes in Pregnancy Dr. Hana

Diabetes in Pregnancy Dr. Hana Diabetes in Pregnancy Dr. Hana Introduction Diabetes occurs in 2 5% of all UK pregnancies and its prevalence is rising. Forty years ago the majority of women with diabetes attending an antenatal clinic

More information

Monthly WellPATH Spotlight November 2016: Diabetes

Monthly WellPATH Spotlight November 2016: Diabetes Monthly WellPATH Spotlight November 2016: Diabetes DIABETES RISK FACTORS & SELF CARE TIPS Diabetes is a condition in which the body does not produce enough insulin or does not use the insulin produced

More information

1990 Obestiy

1990 Obestiy 1990 Obestiy 1995 Obesity 2000 Obesity 2003 Obesity 2006 obesity 2010 Obesity 2013 Obesity 2014 Obesity LIFETIME DIABETES RISK Children born after the year 2,000 One in three Caucasian will develop diabetes

More information

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women

More information

National Aboriginal Diabetes Association. Gestational Diabetes (developed by Sarah Smith, 4 th yr Nursing, University of Manitoba)

National Aboriginal Diabetes Association. Gestational Diabetes (developed by Sarah Smith, 4 th yr Nursing, University of Manitoba) National Aboriginal Diabetes Association Gestational Diabetes (developed by Sarah Smith, 4 th yr Nursing, University of Manitoba) Who we are NADA is a not-for-profit members-led organization established

More information

GDM. Gestational Diabetes Mellitus. Diabetes Clinic, Women s Health Auckland Hospital

GDM. Gestational Diabetes Mellitus. Diabetes Clinic, Women s Health Auckland Hospital GDM Gestational Diabetes Mellitus Diabetes Clinic, Women s Health Auckland Hospital Welcome Haere Mai Respect Manaaki Together Tūhono Aim High Angamua Gestational Diabetes If you have been diagnosed with

More information

Diabetes and Pregnancy

Diabetes and Pregnancy Diabetes and Pregnancy Dr Warren Gillibrand Deputy Director of Postgraduate Education Department of Nursing & Midwifery Department of AHP and Sports Science w.p.gillibrand@hud.ac.uk Aims of the session

More information

Mixed Insulins Pick Me

Mixed Insulins Pick Me Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing

More information

Gestational Diabetes in Rural Antenatal Clinics:

Gestational Diabetes in Rural Antenatal Clinics: Gestational Diabetes in Rural Antenatal Clinics: How do we compare? Cook SJ 1,2, Phelps L 1, Kwan M 2 Darling Downs Health and Hospital Service University of Queensland Rural Clinical School Gestational

More information

Diabetes in Pregnancy Registrar Induction. Dr Anna Dover August 31 st 2015

Diabetes in Pregnancy Registrar Induction. Dr Anna Dover August 31 st 2015 Diabetes in Pregnancy Registrar Induction Dr Anna Dover August 31 st 2015 Outline Joint Antenatal Diabetes Service Pre-existing diabetes Pre-conception, antenatal management Gestational Diabetes Screening,

More information

Pregestational Diabetes in Pregnancy. An Update

Pregestational Diabetes in Pregnancy. An Update Pregestational Diabetes in Pregnancy An Update Disclosures D. Ware Branch, MD Nothing to disclose Questions to Be Addressed What are risks factors for adverse pregnancy outcome in pregestational diabetes?

More information

METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY

METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY 491 METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY ABSTRACT LAVANYA RAI, MEENAKSHI D, ASHA KAMATH 1 OBJECTIVE: To compare the use of metformin with that of insulin

More information

Diagnosis and Management of Gestational Diabetes Mellitus. Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH.

Diagnosis and Management of Gestational Diabetes Mellitus. Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH. Diagnosis and Management of Gestational Diabetes Mellitus Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH. Gestational Diabetes Mellitus I, the Fetus I, the fetus

More information

Learning Objectives. At the conclusion of this module, participants should be better able to:

Learning Objectives. At the conclusion of this module, participants should be better able to: Learning Objectives At the conclusion of this module, participants should be better able to: Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel Develop patient-specific approaches to intravenous

More information

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2 Diabetes Dilemmas: Using Technology To Solve Clinical Conundrums Stephen E. Gitelman, MD UCSF A teenager with type 1 diabetes for 5 years comes into your office for a follow- up visit. You want to review

More information

Diabetes Treatment Update

Diabetes Treatment Update Diabetes Treatment Update Timothy C. Evans, MD PhD FACP University of Washington Department of Medicine Disclosure: Dr. Evans has no significant financial interest in any of the products or manufacturers

More information

V-Go : Simple to start, easy to use

V-Go : Simple to start, easy to use V-Go : Simple to start, easy to use Patient Start Guide Make multiple daily insulin shots a thing of the past. Take control with V-Go. V-Go Customer Care personalized 1-on-1 support for you Call 1-866-881-1209

More information

Why is my Blood Sugar Too High?

Why is my Blood Sugar Too High? What is Gestational Diabetes? Gestational diabetes is a type of diabetes which can occur during pregnancy and usually goes away after the baby is delivered. Gestational means in pregnancy and Diabetes

More information

Diabetes and pregnancy - Antenatal care

Diabetes and pregnancy - Antenatal care Diabetes and pregnancy - Antenatal care Information for you Follow us on Twitter @NHSaaa Find us on Facebook at www.facebook.com/nhsaaa Visit our website: www.nhsaaa.net All our publications are available

More information

Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016

Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Medical Director Sweet Success Sutter Medical Center Sacramento Perinatal Associates of Sacramento

More information

Complete this CE activity online at ProCE.com/InsulinPart2

Complete this CE activity online at ProCE.com/InsulinPart2 Complete this CE activity online at ProCE.com/InsulinPart2 Case 1: A 67 year old male with T2DM History and Presentation John is a 67 year old retiree who has been visiting your pharmacy/clinic for over

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Gestational diabetes: risk assessment, testing, diagnosis and management bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

Subspecialty Procedural Volume Guidelines

Subspecialty Procedural Volume Guidelines Subspecialty Review Committee for Obstetrics and Gynecology In response to requests from program directors, and in an effort to be transparent, the Review Committee for Obstetrics and Gynecology has elected

More information

7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine

7/8/2016. Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine Sol Jacobs MD, FACE Division of Endocrinology Emory University School of Medicine Participation in investigator initiated clinical research supported by: Merck Boehringer Ingelheim Novo Nordisk Astra Zeneca

More information

Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome

Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology

More information

Significant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance

Significant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance What s New in Gestational Diabetes? Diane Reader RD, CDE International Diabetes Center Park Nicollet Health Services Minneapolis, MN GDM Statistics What s New? Proposed Changes to Diagnostic Criteria Treatment

More information

Comprehensive Diabetes Treatment

Comprehensive Diabetes Treatment Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes

More information

The York Diabetes Care Model

The York Diabetes Care Model This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin

More information

In-hospital management of diabetes

In-hospital management of diabetes Dr. Tom Elliott MBBS, FRCPC Medical Director 400-210 W Broadway phone: 604.683.3734 Vancouver, BC fax: 604.628.3821 V5Y 3W2 Canada email: moa@bcdiabetes.ca In-hospital management of diabetes General Management

More information

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy Objectives Diabetes and Obesity in Pregnancy. Health Impact for the mother and child Bresta Miranda, MD Assistant Professor of Clinical Medicine University of Miami, Miller School of Medicine Review physiologic

More information

Diabetes in pregnancy

Diabetes in pregnancy Diabetes in pregnancy Bipin Sethi Department of Endocrinology Care Hospitals Hyderabad, India Declared no potential conflict of interest Diabetes in pregnancy Bipin Kumar Sethi Department of Endocrinology,

More information

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor DIABETES AND PREGNANCY CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor OBJECTIVES Describe targets for blood glucose in pregnancy Discuss the risks to baby if blood glucose

More information

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia Jacqueline LaManna, PhD, ANP BC, BC ADM, CDE Holly Divine, PharmD, BCACP, CGP, CDE, FAPhA Disclosures Dr. Jacqueline LaManna

More information

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8'' IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes

More information

Problems in PCOS pregnancy

Problems in PCOS pregnancy Problems in PCOS pregnancy Miscarriage Admission to NICU Cesarean Section Preeclampsia Mother Prematurity Preterm labour PIH Perinatal mortality Gestational Diabetes Problems with PCOS Pregnancy Problems

More information

TEAMcare Treat-to-Target Tools

TEAMcare Treat-to-Target Tools TEAMcare Treat-to-Target Tools The TEAMcare Treatment Discussion Tool (treatment protocol) Nurse Case Manager (NCM)-MD Treat-to-Target Discussion Tool for Treatment Enhancement Activation and Motivation

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

Endocrinology TeleECHO Clinic Case Presentation Form

Endocrinology TeleECHO Clinic Case Presentation Form Endocrinology TeleECHO Clinic Case Presentation Form Complete ALL ITEMS on this form and fax to 503.228.4801 PLEASE NOTE that case consultations do not create or otherwise establish a provider-patient

More information

Diabetes in Pregnancy: The Risks For Two Patients

Diabetes in Pregnancy: The Risks For Two Patients Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/the-connect-dialogues/diabetes-in-pregnancy-the-risks-for-twopatients/1793/

More information

Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol

Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol *Please note that this guideline may not be appropriate for all patients

More information

HEDIS Documentation and Coding Adult Guidelines 2017

HEDIS Documentation and Coding Adult Guidelines 2017 HEDIS Documentation and Coding Adult Guidelines 2017 Reproduced with permission from HEDIS 2017, Volume 2: Technical Specifications for Health Plans by the National Committee for Quality Assurance (NCQA).

More information

A Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India

A Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 2586-2590 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.304

More information

Comparative Study between Acarbose and Insulin in the Treatment of GDM.

Comparative Study between Acarbose and Insulin in the Treatment of GDM. Original Article DOI: 10.21276/aimdr.2018.4.2.OG5 ISSN (O):2395-2822; ISSN (P):2395-2814 Comparative Study between Acarbose and Insulin in the Treatment of GDM. Minthami Sharon 1, Niloufur Syed Bashutheen

More information

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Pumps & Sensors & Meters, Oh My! A Tale of Two Meters Technology for glucometers

More information

Learning Objectives

Learning Objectives Learning Objectives Assess the key findings of the McMaster meal replacement therapy (MRT) study Identify patients with T2DM who are candidates for MRT Develop a plan to implement partial MRT into a patient

More information